india – pharma.markets

Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines

05/08/2021 MaP 0

….. for Emergency Use Authorization of Novavax’ Recombinant Nanoparticle COVID-19 Vaccine – Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller […]

Daimler is helping during COVID-19 pandemic

01/04/2020 MaP 0

The dimensions of the worldwide COVID-19 pandemic now require society to pool all of its forces. Everybody can contribute to ensure that the exponential growth […]